Understand the source comparison
Comparison Chart: Ipamorelin vs. Other GH Secretagogues in Preclinical Research
Ipamorelin Strong Minimal (preclinical) High selectivity profile observed in animal models GHRP-6 Moderate to High Moderate Earlier generation; less selective GHRP-2 Similar selectivity concerns as GHRP-6 CJC-1295 Minimal Acts on GHRH receptor, not ghrelin rec
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Ipamorelin
- Strong
- Minimal (preclinical)
- High selectivity profile observed in animal models
- GHRP-6
- Moderate to High
- Moderate
- Earlier generation; less selective
- GHRP-2
- Similar selectivity concerns as GHRP-6
- CJC-1295
- Minimal
- Acts on GHRH receptor, not ghrelin receptor; different mechanism
- Sermorelin
- GHRH analog; acts upstream of Ipamorelin's target
- Table 2: Comparative selectivity profiles of common GH secretagogues as characterized in preclinical literature. All data reflects findings from animal model studies only.
- Research Note: The selectivity data in Table 2 reflects findings from preclinical (animal) research. These observations may not translate to human biology. This table is provided for educational and research reference purposes only.
- For researchers interested in related peptides, Palmetto Peptides also provides research-grade CJC-1295, GHRP-6, GHRP-2, and Sermorelin for comparative research applications.